1. Lim, Y.X., et al., Human Coronaviruses: A Review of Virus-Host Interactions. Diseases, 2016. 4(3).
  2. Bermejo-Martin, J.F., et al., COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Cardiovasc Res, 2020. 116(10): p. e132-e133.
  3. Bernard, I., et al., Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses, 2020. 13(1).
  4. Erener, S., Diabetes, infection risk and COVID-19. Mol Metab, 2020. 39: p. 101044.
  5. Gupta, A., et al., Extrapulmonary manifestations of COVID-19. Nat Med, 2020. 26(7): p. 1017-1032.
  6. Hayden, M.R., Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019. J Int Med Res, 2020. 48(7): p. 300060520939746.
  7. Huertas, A., et al., Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J, 2020. 56(1).
  8. Iba, T., et al., Coagulopathy in COVID-19. J Thromb Haemost, 2020. 18(9): p. 2103-2109.
  9. Jain, U., Effect of COVID-19 on the Organs. Cureus, 2020. 12(8): p. e9540.
  10. Loo, J., D.A. Spittle, and M. Newnham, COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax, 2021.
  11. Mosleh, W., et al., Endotheliitis and Endothelial Dysfunction in Patients with COVID-19: Its Role in Thrombosis and Adverse Outcomes. J Clin Med, 2020. 9(6).
  12. Nagashima, S., et al., Endothelial Dysfunction and Thrombosis in Patients With COVID-19-Brief Report. Arterioscler Thromb Vasc Biol, 2020. 40(10): p. 2404-2407.
  13. Sims, J.T., et al., Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19. J Allergy Clin Immunol, 2021. 147(1): p. 107-111.